Posted: May 6, 2024
-Contributed by Abi Kasberg, PhD Attending my first Advanced Technologies & Treatments for Diabetes (ATTD) conference in Florence, Italy this March was a treat for the mind (and palate). Being new to the diabetes space, it was thrilling to learn about the latest insights and advancements that are being made in diabetes research to improve…
Posted: December 21, 2023
David L. McGlasson, MS, MLS(ASCP) A few months ago, I posted on LinkedIn that I noticed at recent conferences and journal articles that blood coagulation factors were sometimes referred to in Euro-Arabic numbers (E-A), 0 through 9, instead of Roman numerals.For example, “F8” was written instead of “FVIII”.And sometimes they are used interchangeably. I received…
Posted: October 24, 2023
-Contributed by Abi Kasberg, PhD Changes have arrived to the field of hepatic steatosis! In efforts to destigmatize and enhance the identification of steatotic liver diseases, several worldwide governing bodies (AASLD, EASL, and ALEH) recently came together to form a multi-stage Delphi panel that assessed, edited, and published changes to the standard nomenclature and diagnostic…
Posted: October 5, 2023
-Contributed by Abi Kasberg, PhD and Olivia Stricker, PhD Neutrophil extracellular traps (NETs) are an amazing participant of the innate immune system. In a first line of defense, neutrophils expel decondensated chromatin into the extracellular matrix to trap invading pathogens in a mechanism called NETosis. NETs are made up of DNA, histones, and granule…
Posted: September 8, 2023
David L. McGlasson, MS, MLS(ASCP) The most recent ISLH meeting was held in New Orleans, LA May 11-13, 2023. The conference had many State-of-the-Art sessions and I concentrated on the hemostasis/thrombosis presentations. On the first day, Katrien Devreese MD, PhD, Ghent University Hospital, Belgium gave an excellent presentation on the current Diagnosis of Acquired Thrombotic…